Clinical Trials
2 trialsNCT06088290 2026-05-15
SaLuDo
PharmaMar
Phase 3 Active not recruiting
NCT07365241 2026-01-26
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
AbbVie
Phase 3 Not yet recruiting